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Cellular barcoding offers a powerful approach to
characterize the growth and differentiation activity
of large numbers of cotransplanted stem cells. Here,
we describe a lentiviral genomic-barcoding and anal-
ysis strategy and its use to compare the clonal out-
puts of transplants of purified mouse and human
basal mammary epithelial cells. We found that both
sources of transplanted cells produced many biline-
age mammary epithelial clones in primary recipients,
although primary clones containing only one detect-
able mammary lineage were also common. Interest-
ingly, regardless of the species of origin,many clones
evident in secondary recipients were not detected in
the primary hosts, and others that were changed
from appearing luminal-restricted to appearing bili-
neage. This barcoding methodology has thus re-
vealed conservation between mice and humans of a
previously unknowndiversity in thegrowth anddiffer-
entiation activities of their basal mammary epithelial
cells stimulated to grow in transplanted hosts.
INTRODUCTION
The output of specialized cells in many tissues involves a
hierarchical differentiation process (Doulatov et al., 2012; Van
Keymeulen and Blanpain, 2012) that originates in a rare tis-
sue-specified stem cell population. Although many approaches
have helped to delineate the properties of individual cells within
these tissue hierarchies, all have limitations. In vitro systems are
generally unable to be sustained for the long periods of mature
cell output required to identify the most primitive elements, and
in vivo approaches are constrained by the large numbers of an-
imals needed to accrue data about the regenerative propertiesCeof single cells. The use of DNA-based genome markers facili-
tates clonal analyses, historically, most frequently applied
to the study of hematopoiesis by detecting the semirandom
genomic sites of integration of a viral vector in the progeny of
initially transduced hematopoietic stem cells (Schmidt et al.,
2009). The resolution of this approach has been increased
substantially with the advent of linear amplification-mediated
PCR (LAM-PCR) (Kustikova et al., 2008) coupled with massively
parallel sequencing (MPS) technology (Arens et al., 2012).
However, LAM-PCR-based methodologies are not well suited
to deriving clone size estimates and do not sensitively detect
small clones. The use of libraries of barcoded vectors can over-
come many of these limitations provided appropriate analytical
methods are used to circumvent library-specific molecular
biases, accumulated errors inherent in MPS, and transduction
of cells with more than a single integrated barcode sequence,
as recently shown for tracking clones derived from barcoded
mouse (Bystrykh et al., 2012; Gerrits et al., 2010; Lu et al.,
2011; Naik et al., 2013; Schepers et al., 2008) and human hem-
atopoietc cell transplants (Cheung et al., 2013).
We now describe a multiplexed, high-resolution methodol-
ogy suitable for deconvoluting barcode sequence data from
expanded populations of cells originally transducedwith a library
of barcoded lentiviruses. We also show how application of this
technology to serial transplants of basal mammary epithelial
cells isolated from normal adult mouse and human glands can
identify a conserved diversity of clonal growth and differentiation
patterns and confirm results previously generated from analysis
of limiting dilution transplants (Eirew et al., 2008; Lim et al., 2009;
Shackleton et al., 2006; Stingl et al., 2006).RESULTS
Generation of an Unbiased High-Throughput
Multiplexed Cellular Barcoding Methodology
We constructed a library of MNDU3-PGK-GFP (Logan et al.,
2004) lentiviral vectors containing a 27-nucleotide noncodingll Stem Cell 14, 253–263, February 6, 2014 ª2014 Elsevier Inc. 253
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Figure 1. Cellular Barcoding Using MPS for
Quantitative Clonal Tracking Studies
(A) Workflow of the barcoding methodology.
Degenerate nucleotides for the variable regions in
the barcode sequence are indicated with an N or
S. At the end of the experiment, the barcode
composition is determined using spiked-in control
cell extracts added to each library. For details, see
text and the Experimental Procedures.
(B) Relationship between absolute cell number and
the fractional read value (the normalized barcode
read abundance value) for the MPS data from the
third MPS run. The solid black line indicates the
linear regression fitted to the data with the 95%CIs
for the relationship parameters shaded in gray. The
threshold indicated is the fractional read repre-
sentation equivalent to approximately 20 cells.
(C) Sensitivity measurements for the 28 sets of
replicate control libraries analyzed.
(D) Reproducibility of clone detection with respect
to clone size in seven replicate libraries (Table S5).
Solid bars indicate clones detected in both
libraries and open bars indicate clones detected
in only one of the two. Dotted lines indicate the
mode of the size distributions.
(E) Experimental design of the mammary cell
transplant experiments.
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Cellular Barcoding of Transplanted Mammary Cellsbarcode sequence designed as previously described (Gerrits
et al., 2010) (Figure 1A). From >106 bacterial colonies, Sanger
sequencing confirmed the accuracy and efficiency of the
plasmid cloning (Table S1 available online) and MPS data indi-
cated a diversity of 2 3 105 unique barcodes (Figure S1A) and
no systematic bias in read abundance. Analysis of PCR-ampli-
fied barcodes from genomic DNA extracted from primary human
mammary cells transduced with the virus library generated from
these plasmids showed these were contained within a 2-fold
range of sequence reads (mean ± SD = 624 ± 157; Figure S1A).
Establishment of Thresholds for Clone Identification
and Absolute Size Determinations
To correct for variables inherent in genomic DNA extraction and/
or construction of molecular libraries for sequencing, we added
a set of control samples to each experimental sample to serve
as an internal calibration. These ‘‘spiked-in’’ controls consisted
of defined numbers of cells containing known barcodes and
covered the expected range of experimental clone sizes
(Table S2). To normalize barcode abundance values that vary254 Cell Stem Cell 14, 253–263, February 6, 2014 ª2014 Elsevier Inc.in sequence coverage between libraries,
each spiked-in control was converted to
its fraction of sequences for all of the
spiked-in controls in its respective in-
dexed library (Table S3). For a total of 80
sets of spiked-in controls from three
experimental data sets, we used regres-
sion analyses to establish the relationship
between the fractional representation of
each barcode and the number of cells
from which the spiked-in sequences had
been obtained (Figure 1B; Tables S2and S3; Figure S1B). To establish a confidence threshold for
the first two MPS runs, which had an SD of less than three cells
across all groups (Table S4), we calculated the fractional repre-
sentation of sequence reads in the spiked-in controls (the
minimal fractional representation after normalization) using a sin-
gle-cell threshold. In the third MPS run, an increased sensitivity
and reduced specificity was observed (revealed by a larger
SD, <44 cells, and wider 95% confidence interval [CI] across
all groups; Table S4). Hence, a lower threshold corresponding
to 20 cells was used in this case. The variation in regression
data obtained from these different MPS runs highlights the
importance of the spiked-in controls.
Application of these thresholds to virtual data sets from each
of the three corresponding MPS runs (a total of 28 sets of control
libraries constructed from the spiked-in control cells) showed
that all clones of >500 cells were detected (100% sensitivity; Fig-
ure 1C), the 100-cell clones were detected with 55%–100%
sensitivity, and the 20-cell clones were detected with 18%–
67% sensitivity. The specificity of detecting ‘‘true’’ clones was
shown to be >99% (Table S4), based on finding only 1 of the
Figure 2. Regeneration ofMorphologically NormalMouseMammary
Glands from Transplants of Barcoded Mouse Basal Mammary
Epithelial Cells
Images showing the GFP+ cell contribution to a gland structure generated in a
fat pad from barcoded mouse basal mammary epithelial cells, as well as he-
matoxylin and eosin (H&E) and immunohistochemical staining for cytokeratin 8
(K8), a marker of luminal cells, and cytokeratin 14 (K14) and smooth muscle
actin (SMA), two markers of basal cells. Positive immunohistochemical
staining is pink and all slides are counterstained with hematoxylin. White and
black scale bars indicate 1 mm and 20 mm, respectively.
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Cellular Barcoding of Transplanted Mammary Cells2,687 false-positive barcodes in the 28 control libraries to be
above the defined threshold.
Reproducibility of clone detection was determined from an
analysis of seven pairs of replicate data sets obtained from the
DNA of transducedmousemammary epithelial cells that had un-
dergone clonal expansion in vivo followed by 1 week of further
amplification of the cells in vitro. Paired data sets were generated
by splitting each of the seven DNA extracts into two equal frac-
tions that were then individually subjected to library construction
and sequencing. Of the 113 clones identified in these 14 data
sets, 88 were detected in both replicates of each pair (Table
S5) and yielded clone size values of 26 to 12,235 cells. Clones
detected in only one replicate were generally smaller (mean ±
SD = 34 ± 31 cells) than clones detected in both (mean ± SD =
1,091 ± 2,091 cells), consistent with an increased likelihood of
uneven sampling for clones containing <100 cells (Figure 1D).
Previously described vector-based genomic barcoding strate-
gies have relied on statistical modeling to determine conditions
for lentiviral transduction that minimize the incidence of multiple
barcode integrations by reducing the transduction efficiency
to %30% (Lu et al., 2011). We mimicked this approach using a
slightly different transduction protocol (Imren et al., 2004) and
then examined this issue directly by determining the 95% CI of
the sizes estimated for each of our known spiked-in control sam-
ples. From the correlations obtained (R2 = 0.94, R2 = 0.86, and
R2 = 0.70 for the three MPS runs, respectively; Table S4), we
calculated the 95% CI associated with each individual value
and grouped clones to eliminate redundant barcodes (likely
derived from a single cell) where the 95% CI overlapped (Table
S6). To measure directly the frequency of cells that would
contain more than one integrated barcode under the conditions
used for the primary cells, we applied this transduction protocol
to cells from the 184-hTERT immortalized ‘‘normal’’ human
mammary epithelial cell line (Raouf et al., 2005), 48 hr later iso-
lated single GFP+ cells by fluorescence-activated cell sortingCe(FACS), expanded them individually in vitro, and then examined
the number of viral integration sites in each clone by Southern
blotting. Analysis of 23 such clones showed 21 (90%) contained
a single integrant (Figure S1C). This represents a lower frequency
than identified by overlapping 95% CI (Table S6), indicating that
a CI-based methodology is effective at removing multiple bar-
code integration events.
Transplanted Mouse Basal Mammary Epithelial Cells
Display Both Restricted and Bilineage Differentiation
Patterns in Primary Recipients
We first investigated the clonal patterns of growth and differenti-
ation obtained when barcoded basal mammary epithelial cells
isolated from normal adult virgin mice are transplanted at
nonlimiting numbers into the cleared fat pad of primary and sec-
ondary syngeneic recipients (Figure 1E). CD45Ter119BP-
1CD31EpCAM+CD49f++ (operationally referred to hereafter
as ‘‘basal’’) mammary epithelial cells were obtained by FACS
at >97% purity (Figure S1D) using gates previously shown to
enrich for both mammary repopulating units (MRUs) (Shackleton
et al., 2006; Stingl et al., 2006) and cells that form adherent
epidermal growth factor (EGF)-dependent colonies in vitro under
hypoxic conditions (colony-forming cells [CFCs]) (Makaremet al.,
2013; Smalley, 2010).We then transduced these cells using a 4 hr
infection protocol expected to deliver a single integrated viral
gene in >90% of the transduced cells (Figure S1C). In a first
experiment, the cells were cultured for 7 days to allow expression
of the GFP reporter with minimal expansion, and the GFP+ cells
(30%) present at the end of that period were then isolated by
FACS and transplanted (6 3 104/fat pad, grafts 1–4). Seven
weeks later, the regenerated glands were removed and the total
GFP+EpCAM+CD49f++ (basal) and GFP+EpCAM++CD49f+ (oper-
ationally referred to hereafter as ‘‘luminal’’) cell populations were
isolated fromeach fat pad by FACS (>97%purity; Table S7). DNA
extracts were then prepared directly from 40%and 90%of these
GFP+ cells, respectively, to determine their barcode composition
directly by MPS. Another 10% of each sorted fraction was first
expanded in vitro (under CFC assay conditions) and then DNA
extracts obtained and sequenced to extend the primary clone
data. The remaining 50% of the original regenerated basal
cells harvested from each primary fat pad were transplanted
into a cleared fat pad in a secondary mouse and their outputs
assessed another 12 weeks later (Figure 1E). In a second exper-
iment, barcoded basal cells were transplanted immediately
following the 4 hr exposure to virus at cell doses of 5 3 104 and
104 per fat pad (two fat pads per cell dose for grafts 5, 6 and
7, 8, respectively). FACS analysis of a separate aliquot of these
cells cultured for another 48 hr demonstrated 36% of the
cells to be GFP+. Eight weeks posttransplant, histological,
immunochemical, and in vitro CFC content analysis of the regen-
erated mammary structures confirmed their normal organization
and composition (Figure 2). This included the presence of the
recently described (Shehata et al., 2012) Sca1+ (non-CFC-con-
taining) andSca1 (CFC-containing) subsets of luminal cells (Fig-
ure S1E). Approximately 90% of the total barcoded (GFP+Sca1+
and GFP+Sca1) luminal cells and 50% of the matching GFP+
basal cells harvested from the remaining fat pads in this second
experiment were then analyzed directly for their barcode content
by MPS.ll Stem Cell 14, 253–263, February 6, 2014 ª2014 Elsevier Inc. 255
Figure 3. Detection of Barcoded Clones
by MPS from Transplanted Mouse Basal
Mammary Cells
(A) Depiction of all clones detected in the four fat
pads (1–4) of the primary (1) mice and, where
relevant, in the transplanted fat pads of secondary
(2) recipients from the first such experiment. The
y axis is the clone number ID within each individual
fat pad analyzed.
(B) Similar data for the clones detected in the four
fat pads transplanted with cells from the second
experiment (#5 to #8). In all experiments, the col-
umns refer to the clones detected in the cells
isolated directly from the in vivo assay (A) or after
a further 1-week expansion in vitro (B).
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the primary mice transplanted with cells cultured for 7 days
following transduction identified a total of 144 clones (112 from
the directly analyzed cells and another 32 from the cells that
were expanded in vitro prior to DNA extraction; Figure 3A; Table
S8) with amaximumclone size of 8,660 cells (Figure 4A). Approx-
imately 40% (45/112) of the regenerated clones and all of the 27
largest clones (>400 cells/clone) were bilineage containing
basal and luminal progeny in approximately equivalent numbers
over a large range of clone sizes (Figures 4A and 4B). In the
other 67 primary clones in this experiment, only luminal
cells (56/112), or only basal cells (11/112), were detected (Fig-
ure 4A). Although the average size of these single-lineage
clones was smaller than that of the bilineage clones, some
contained as many as 380 cells, thus arguing against the
detection of a restricted lineage content being explained by
a smaller clone size. However, a number of clones of <100
cells must have been missed, because not all the GFP+ cells256 Cell Stem Cell 14, 253–263, February 6, 2014 ª2014 Elsevier Inc.detected could be confidently assigned
to a particular clone (Table S7).
In the mice transplanted with cells
directly following transduction, we identi-
fied a total of 611 primary clones (374 in
the fat pads injected with 5 3 104 cells
each and 237 in the fat pads injected
with 104 cells each; Figure 3B) and the
results for the two transplant doses
were similar (Figure 4C). On average, all
three different types of clones were larger
than in the first experiment (some single-
lineage clones containing up to 6,000
cells), but their overall representation
remained similar to the results obtained
in the first experiment, with the clones
containing only luminal cells being the
most prevalent and those containing
only basal cells being the least prevalent.
As in the previous experiment, many
bilineage clones contained equivalent
numbers of basal and luminal cells,
although examples of greater bias were
noted in the second experiment. More
detailed analysis of the Sca1+ andSca1 fractions within the luminal populations present in both
the bilineage and luminal-restricted clones showed that both
included some in which only Sca1+ or only Sca1 cells were
detected, but these were generally small, near the limit of detec-
tion. In contrast, those in which both Sca1+ and Sca1 cells were
detected were a common feature of the largest clones contain-
ing luminal cells, regardless of whether basal cells were also
detectable in them (Figures 5A and 5B). However, the presence
of themore primitive Sca1 luminal cells was a significantly more
common feature of the luminal-restricted clones compared to
the bilineage clones (47% versus 18%; p = 0.023).
Secondary Clones Generated from Primary Nonlimiting
Transplants of Mouse Basal Mammary Epithelial Cells
Reveal Unexpected Patterns of Growth and
Differentiation
Secondary recipients of barcoded mouse mammary cells were
also set up in the first experiment (where 50% of the basal cells
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Cellular Barcoding of Transplanted Mammary Cellsharvested from each of the four primary fat pads were injected
into two secondary fat pads and the pairs pooled 12 weeks later,
at which time the regenerated cells were again isolated by
phenotype and analyzed by MPS; Figure 1E). From these ana-
lyses, we identified a total of 63 clones in the secondary mice
(Figures 3A, 3B, and 6A) and found that they spanned the
same range of sizes (up to 8,160 cells) and types as the clones
obtained in the primary mice from which they had been derived
(Figure 4A). Strikingly, 48% (30/63) of the clones detected in the
secondary mice had not attained a detectable size in the primary
mice (Figure 6A). Moreover, the features of the corresponding
primary clones predicted neither the differentiation pattern nor
the size of the other 33 clones evident in the secondary mice.
In fact, very few primary clones that were exclusively basal
were self-perpetuating and most clones detected in the second-
ary mice were small (100 cells) and only contained a single line-
age. On the other hand, 15 clones that initially appeared to be
luminal restricted and small (<200 cells) became robustly biline-
age (300–8,000 cells) in secondary hosts (a 300-fold expansion
in clone size in some instances; Figure 6B). Conversely, four
initially bilineage clones produced only a single lineage in sec-
ondary hosts, with 11 continuing to display robust bilineage
activity. These results show that a display of bilineage differenti-
ation activity in primary mice is not a universal feature of cells
with serially transplantable regenerative activity, nor does the
differentiation activity displayed after 7 weeks by transplanted
basal cells necessarily reflect their full differentiation potential.
Interestingly, most of the 30 clones that first became evident
in the secondary mice were either bilineage (53%) or basal
restricted (37%) and the three clones (10%) that appeared
luminal restricted were small, making it difficult to exclude a
potential content of basal cells. Thus, delayed clonal growth at
least in transplants of nonlimiting numbers of cells with regener-
ative potential may be associated with predominantly basal or
bilineage differentiation ability.
Serially Transplanted Human Basal Mammary Epithelial
Cells Can Also Show Diverse and Delayed Regenerative
Activities
We also examined the outputs of clones obtained from nonlimit-
ing numbers of barcoded human basal mammary epithelial cells
transplanted into immune-deficient mice using a protocol that
allows bipotent human mammary ‘‘stem’’ cells to be detected
and quantified (Eirew et al., 2008). Here, we isolated the popula-
tion operationally referred to hereafter as ‘‘basal’’ at >97% purity
by FACS based on their CD45CD31CD10+CD90+CD49f+
phenotype (Raouf et al., 2008) from three different normal mam-
moplasty samples (Figure S1F), transduced the cells from each
using the same 4 hr protocol as for the experiments with bar-
coded mouse mammary cells, and then embedded 1.5 3 104
cells into each of two collagen gels that were subsequently im-
planted under the kidney capsule of three nonobese diabetic se-
vere combined immunodeficiency interleukin-2Rgc-null (NSG)
mice. In the first two experiments, the transduced human cells
were cultured for another 3 days prior to isolating the GFP+ sub-
set (35%–38%) of cells with the same CD45CD31CD10+
CD90+CD49f+ phenotype (retained by >95% of the cells under
these conditions) before being transplanted. In a third experi-
ment, the 1.5 3 104 cells were embedded into each gel and im-Ceplanted immediately posttransduction, with a separate aliquot
cultured for 48 hr to determine the transduction efficiency
(40%, hence 6 3 103 GFP+ cells per gel). In all experiments,
the gels were harvested 4 weeks later and both human GFP+
CD10+CD90+CD49f+ (basal) and GFP+CD10CD90EpCAM+
and/or Muc1+ (operationally referred to hereafter as ‘‘luminal’’)
cells were isolated by FACS from the gels at >97% purity (Fig-
ure S1G; 3,500 GFP+ cells in each experiment). A proportion of
these cells were then analyzed for their barcode content directly,
and some after expanding their numbers in vitro (Figure 1E). In
the first experiment, 40% of the recovered basal cells were set
aside and transplanted in collagen gels under the kidney capsule
of secondary NSG mice and the cells present in the gels
analyzed another 4 weeks later (Figures 1E and S1G). Histolog-
ical and immunochemical analysis of gels containing similarly
transduced cells confirmed the expected organization and
cellular content of the structures regenerated (Figure 7A).
In the first two experiments, a total of 39 clones were detected
(Figure 7B), with the majority detected uniquely from a cell
aliquot that was expanded in vitro before being sequenced
(37 of 39 clones). In the third experiment, primary clone yields
were based exclusively on cells that were first expanded
in vitro (50% of the basal cells and 100% of the luminal cells)
and a total of 90 clones were detected (Figure 7B; Table S8).
Basal-restricted, luminal-restricted, and bilineage clones were
observed in all three experiments, but their distributions were
highly variant even when restricted to analysis of the expanded
cells (5:89:5 for xenograft 1, 22:17:61 for xenograft 2, and
33:37:30 for xenograft 3, respectively; Figure 7C). In the first
experiment in which secondary transplants were performed,
we identified 17 clones. All of the clones identified from the sec-
ondary grafts were significantly larger than, and not detected
among, those evident in the primary grafts (an average of 246
versus 35 cells per clone, respectively; p = 0.018; Figure 7D).
DISCUSSION
Current concepts of the mammary epithelial differentiation pro-
cess posits that cells within the basal epithelial fraction are
capable of generating both basal and luminal progeny in a hier-
archical process that couples lineage restriction and differentia-
tion with decreasing proliferative potential. The most primitive of
these in the mammary gland of adult mice and humans were first
detected and quantified by their ability at limiting dilutions or as
single-cell transplants to regenerate functional mammary tissue
of normal composition and structural organization in the cleared
fat pad of syngeneic prepubertal mice (Lim et al., 2009; Shackle-
ton et al., 2006; Stingl et al., 2006) or in collagen gel implants
placed under the kidney capsule of immune-deficient mice
(Eirew et al., 2008; Shehata et al., 2012). MRU is the operational
term that has been used to refer to these cells and, in both spe-
cies, the majority of cells thus identified have been found to
display a similar basal phenotype (Eirew et al., 2008, 2010;
Shackleton et al., 2006; Stingl et al., 2006). However, we and
others have recently reported evidence of mouse cells with a
luminal cell surface phenotype but able to display or reactivate
the regenerative properties of MRUs (Makarem et al., 2013;
Regan et al., 2012; Shehata et al., 2012). Even for transplanted
cells with a basal phenotype, the variability in size and lineagell Stem Cell 14, 253–263, February 6, 2014 ª2014 Elsevier Inc. 257
Figure 4. Different Patterns of Growth and Differentiation in Mouse Mammary Clones Produced in Primary and Secondary Recipients
(A) Distributions of total clone size (binned by log2 increments) for clones detected in primary (left) and secondary mice (right). Pie charts indicate the proportion of
bilineage (magenta), luminal-restricted (red), and basal-restricted (blue) clones for either primary (left, solid colors) or secondary (right, colors with white stripes)
(legend continued on next page)
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Figure 5. Sca1+ and Sca1– Luminal Cell
Content within Bilineage and Luminal-
Restricted Clones
(A) The scatterplot shows the numbers of Sca1
(y axis) and Sca1+ (x axis) cells from the luminal
fraction of bilineage (left) or luminal-restricted
clones (right) detected in primary mice trans-
planted with 5 3 104 basal mammary cells. The
stacked column shows the proportion of either the
bilineage or luminal-restricted clones that were
found to contain exclusively Sca1 cells (dark red),
Sca1+ cells (yellow), or both cell types (light red).
(B) Same as (A), for clones in primary mice trans-
planted with 104 basal mammary cells.
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Cellular Barcoding of Transplanted Mammary Cellscomposition of clones they may generate and the frequency and
lineage output properties of those with extensive self-renewal
ability has remained unclear, particularly for serial transplants
containing nonlimiting MRU numbers.
The barcoding methodology applied here detected the gener-
ation of 792mouse clones and 146 human clones in recipients of
transduced basal mammary cells (one GFP+ clone per 450 and
500 transplanted GFP+ mouse and human basal cells, respec-
tively). Analysis of the time of appearance, longevity, size, and
lineage content of these clones showed some, but not all, as-
pects of these functional properties to be consistent with the
regenerative activities of MRUs, with some new insights into
the behavior of nonlimiting transplants of basal cells (Figure S2).
For example, the prevalence of both human and mouse basal
cell-derived bilineage clones containing cells that could prolifer-
ate extensively in vitro is consistent with the expected recon-
struction of a fully constituted normal mammary gland from
single basal mammary stem cells. However, it has now become
possible to quantify the frequency of such mouse bilineage
clones that contain progeny with the same bilineage activity
demonstrable in secondary recipients (30%)—the classical func-
tional test of self-renewal. We also showed that mouse bilineagemice. The scatterplots below show numbers of basal and/or luminal progeny in each of these clones (solid circ
mice). In these, the dotted line indicates the minimum threshold of reproducible clone detection (100 cells).
(B) Size distributions for the three primary and secondary clone types indicated in (A) (i.e., defined accordin
(C) Distributions of total clone size (binned by log2 increments) for clones detected from fat pads trans
cells. Dotted lines indicate the mode of each size distribution plot. Pie charts indicate the proportion
and basal-restricted (blue) clones for either the 5 3 104 (left) or the 104 (right) transplant doses. T
and/or luminal progeny in each of the clones shown above. In these, the dotted line indicates the min
(100 cells).
(D) Size distributions for the three clone types indicated in (C) (i.e., defined according to their lineage content
indicate the mode of the distribution.
Cell Stem Cell 14, 253–263clones have a consistently reduced con-
tent of luminal cells (50% as compared
to the 75% value for the normal resting
adult mammary gland), as previously
documented for human MRU transplants
(Eirew et al., 2008), with the remaining
proportion of luminal cells contributed
by highly prevalent smaller clones with
exclusively luminal progeny (at our detec-
tion limit). It is important to note, however,
that the cell surface phenotypes widelyused to identify dissociated basal and luminal mammary epithe-
lial cells do not always correlate with other properties associated
with these cells in the normal adult gland. Indeed, there is
now growing evidence of subsets within these populations as
well as examples of variant phenotypes during development
(Makarem et al., 2013; Spike et al., 2012), aging (Kannan et al.,
2013), pregnancy (Choudhury et al., 2013), and stages of the
menstrual cycle (Joshi et al., 2010).
The most intriguing findings encountered here were the high
frequency of clones that were not detected until their transfer
to secondary mice and the frequency of primary clones that
contained exclusively luminal cells in spite of their origin from
a cell with a basal phenotype in transplants of both mouse
and human cells (Figure S2). The latter could identify a previ-
ously unrecognized type of committed progenitor with extensive
but limited proliferative ability. On the other hand, such an
outcome could also be explained by a stochastic mechanism
affecting lineage commitment. Nevertheless, neither of these
possibilities explains the frequency of conversion of primary
luminal clones into bilineage clones in secondary mice. These
findings set the stage for future experiments to investigate these
possibilities.les for primary mice and open circles for secondary
g to their lineage content).
planted with 5 3 104 (left) and 104 (right) basal
of bilineage (magenta), luminal-restricted (red),
he scatterplots below show numbers of basal
imum threshold of reproducible clone detection
). All dotted lines in size distribution plots in (A)–(D)
, February 6, 2014 ª2014 Elsevier Inc. 259
Figure 6. Diverse Size and Lineage Composition of Mouse
Mammary Clones Detected in Secondary Mice
(A) Pie charts show the proportion of continuing (left) and new (right) clones that
were bilineage (magenta with white stripes), luminal restricted (red with white
stripes), and basal restricted (blue with white stripes) in the secondary (2)
mice.
(B) Pie charts show the proportions of bilineage, luminal-restricted, and basal-
restricted clones detected in the primary (1) mice that gave rise to detectable
clones in the 2 mice. For each of these, the proportion of clones from the
primary mice that did not reappear in the secondary mice are shown in gray
with white stripes, and for those that continued, the proportion of clones that
were bilineage (magenta with white stripes), luminal restricted (red with white
stripes), and basal restricted (blue with white stripes) in the secondarymice are
also shown. The scatterplots directly beside each pie chart compare the sizes
of thematching clones in the 1 and 2 mice. Dotted lines indicate theminimum
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under conditions where many clones are stimulated to grow
and differentiate simultaneously. In this situation, complex inter-
actions may suppress the expression of particular lineage
growth and differentiation programs and thus contribute to a
diversity of clone types not fully reflective of the potential of the
cell of origin. Recent in vivo lineage-tracing experiments in the
mouse have highlighted examples of variably restricted expres-
sion of the growth and differentiation activities displayed by
mouse basal and luminal epithelial cells both in situ and following
their transplantation into cleared fat pads (van Amerongen et al.,
2012; Van Keymeulen et al., 2011). Here, we show how this var-
iable behavior can be readily quantified at a clonal level and
extend it to include kinetic patterns revealed in serial transplants
that would not otherwise be observed in situ or from transplants
of limiting numbers of cells.
Currently, most studies examining the subclonal heterogene-
ity of breast tumors (Curtis et al., 2012; Shah et al., 2012), as
well as tumors derived from other solid tissues (Gerlinger et al.,
2012; Welch et al., 2012), rely on whole-genome sequencing
data to identify and track subclones based on the relative prev-
alence of different mutations.We envisage that the application of
cellular barcoding employing MPS and the analytical protocols
described here will enable more complete information to be
obtained about the heterogeneous growth of transplantable
tumorigenic subclones, including the roles of specific genetic
or epigenetic alterations and different treatments on their biology
in syngeneic or xenografted mice.
EXPERIMENTAL PROCEDURES
Barcode Library Construction
Barcode oligonucleotides were designed using forward (50-TCGAGAAGTAA
NNATCNNGATSSAAANNGGTNNAACNNTGTAAAACGACGGCCAGTGAGC-
30) and reverse (50-CCGGGCTCACTGGCCGTCGTTTTACANNGTTNNACCN
NTTTSSATCNNGATNNTTACTTC-30 ) oligonucleotide sequences flanked by
a 50 XhoI restriction site and a 30 XmaI restriction site that were ordered (Life
Technologies) with a 50 phosphorylation modification, annealed in an equi-
molar ratio, and directly ligated into the MPG vector (Logan et al., 2004) down-
stream of the GFP reporter cDNA. DH10B bacteria (Life Technologies) were
transformed with the ligated vector and plated at clonal density onto ampi-
cillin-terrific broth (Life Technologies) agar plates. An initial 141 bacterial col-
onies were individually picked and analyzed by Sanger sequencing (Table
S1). The bacterial colonies were pooled and homogenized and plasmids
were purified following the manufacturer’s recommendations (MaxiPrep,
QIAGEN) and the purified plasmids used for production of lentiviral packaging
as previously described (Imren et al., 2004). A high-titer virus (109 infectious
units/ml), as determined from assays on HeLa cells, was obtained.
Mouse and Human Mammary Cell Preparation
Mouse mammary glands were isolated from 8- to 12-week-old normal virgin
female C57Bl/6J mice and single-cell suspensions generated (Stingl et al.,
2006). To purify specific subsets of mouse cells, nonspecific antibody binding
was blocked with rat serum (Sigma) and anti-mouse CD16/32 Fc-gamma III/II
receptor antibody. Mouse mammary cells were then depleted of hematopoi-
etic and endothelial cells using biotinylated antibodies to mouse CD45 and
CD31, respectively, and stromal cells using biotinylated antibodies to mousethreshold of reproducible clone detection (100 cells). Each point represents
one of the continuing clones, the color of which indicates the composition of
each clone in the secondary mouse: bilineage (purple open dot), luminal (red
open dot), basal (blue open dot), and not detected (gray open dot).
.
Figure 7. Distribution of the Size and LineageComposition of Clones
Generated in Primary and Secondary Recipients of Normal Human
Basal Mammary Epithelial Cells
(A) Histology of bilayered structures generated from barcoded human basal
mammary epithelial cells in collagen gels xenografted under the kidney
capsule of NSG mice. The top left panel shows hematoxylin and eosin (H&E)
staining only. The remaining panels show immunohistochemical staining for
cytokeratin 14 (K14) and MUC1, two markers of luminal cells, and cytokeratin
8/18 (K8/18) and smooth muscle actin (SMA), two markers of basal cells.
Positive staining is shown as pink, and all sections were counterstained with
hematoxylin. Black scale bars indicate 20 mm.
(B) Depiction of all clones detected in the human xenografts. The x axis shows
each clone according to its ID, and the same clones are then identified by the
horizontally aligned bars, with the columns showing all total clones detected in
Cell Stem Cell
Cellular Barcoding of Transplanted Mammary Cells
CeTER-119 and BP-1, followed by streptavidin-phycoerythrin (PE) or streptavi-
din-Brilliant Violet 421. Allophycocyanin (APC)-conjugated antibody to mouse
CD49f, PerCP-Cy5.5-conjugated anti-mouse CD326 (EpCAM), and PE/
cyanine (Cy)-7-conjugated anti-mouse Sca1 were used to isolate the fractions
desired (see Table S9).
Human mammary cells were isolated from normal reduction mammoplasty
tissue obtained with informed consent according to procedures approved by
the research ethics board of the University of British Columbia and processed
as described elsewhere (Eirew et al., 2008). Human hematopoietic and endo-
thelial cells were depleted using antibodies to human CD45 and CD31 and the
fractions studied then isolated after staining with PE-conjugated antibodies to
human CD10 and CD90 (Thy1), APC-conjugated antibody to human CD49f,
PerCP-Cy5.5-conjugated antibody to human EpCAM, and unconjugated anti-
body to CD227, followed by a secondary goat anti-mouse antibody (Table S9).
Both mouse and human cells were then exposed to 40, 60-diamidino-2-phenyl-
indole (DAPI) to eliminate dead (DAPI+) cells and subsets isolated using a
FACS Aria II or Influx II cell sorter (BD Biosciences).
Transduction and Preculture of Mouse and Human Mammary Cells
Mousemammary cells were transduced in a liquid suspension culture contain-
ing 100 ml of Dulbecco’s modified Eagle’s medium/F12 (3:1, STEMCELL Tech-
nologies), 10% fetal bovine serum (FBS), 10 ng/ml EGF (Sigma), 1.83 104 M
adenine (Sigma), 5 mg/ml insulin, 0.5 mg/ml hydrocortisone, 1010 M cholera
toxin (Sigma), and 10 mM Y-27632 (Reagents Direct) with virus added at a
1:200 dilution for 4 hr at 37C, washed with Hank’s balanced salt solution
(STEMCELL Technologies) supplemented with 2% FBS and then cultured
on tissue culture plates coated with Matrigel (1:60, BD Biosciences) for
7 days at 5% O2 prior to harvesting for transplantation or were transplanted
immediately following infection. Human mammary cells were similarly trans-
duced in SF-7 media (Raouf et al., 2008) and then cultured for 3 days on tissue
culture plates coated with Matrigel (1:60) in SF-7 media with 2% FBS at 20%
O2 prior to harvesting for transplantation or were transplanted immediately
following infection.
In Vivo Transplantation of Mouse and Human Mammary Cells
Mouse mammary cells were transplanted into cleared mammary fat pads of
prepubertal virgin female C57Bl/6J mice as previously described (Stingl
et al., 2006) but withMatrigel (25% v/v, BDBiosciences) added to the cell inoc-
ulum and a silicone elastomer pellet containing 2 mg 17b-estradiol and 4 mg
progesterone (Sigma) implanted subcutaneously 4 weeks posttransplant.
Another 3–4 weeks later, the cells were retrieved for analysis, two-dimensional
CFC assays, and secondary transplants (which were analyzed another
12 weeks later). Human mammary cells suspended in solidified collagen
gels were implanted under the kidney capsule of 5- to 8-week-old virgin female
NSG mice. Four weeks later, the gel implants were retrieved and a single-cell
suspension prepared (Eirew et al., 2010; Eirew et al., 2008), similarly analyzed,
and transplanted into a secondary mouse (which was analyzed another
3 weeks later). All procedures involving mice were approved by the animal
care committee of the University of British Columbia.
Mouse and Human 2D CFC Assays
CFC assays of mouse mammary cells were performed by culturing the cells in
the presence of irradiated 3T3 fibroblasts at 5% O2 for 7 days in the same
growth media used for transductions (see above). CFC assays of human
mammary cells were performed by culturing the cells in the presence of
irradiated 3T3 fibroblasts for 8 to 10 days in serum-free SF-7 media (Eirew
et al., 2012).the directly isolated cells (A) or in the cells that had first been expanded for an
additional 1 week in vitro (B).
(C) Pie charts indicate the proportion of clone types defined according to their
content of basal and/or luminal cells and/or progeny derived in vitro (‘‘n’’ is the
total number of clones detected in the in vitro-expanded cells). The number on
the top left of each graph corresponds to the xenografts in (B).
(D) Total size of each clone measured in primary (1) and secondary (2)
mice derived from xenograft 2 (basal = blue, luminal = red, and total
cells = black).
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Fat pads containing regenerated mouse mammary tissue and collagen gels
containing regenerated human mammary tissue were fixed in 10% buffered
formalin (Fisher), washed in 70% ethanol, and embedded in paraffin. We
treated 4 mm sections first with Target Retrieval solution (DAKO) and then
Cleanvision solution (Immunologic) for mouse tissues and cytomation
serum-free protein block (DAKO) for human tissues. Sections of both were
stained with an anti-cytokeratin 14 antibody (Clone NCL-LL002, Novacas-
tra), an anti-MUC1 antibody (Clone 214D4, STEMCELL Technologies), or
an anti-smooth muscle actin antibody (Clone 1A4, DAKO), all of which are
cross-reactive for both mouse and human cells. An anti-cytokeratin 8 anti-
body (ab59400, polyclonal, Abcam) or anti-cytokeratin 18 antibody (Clone
E431-1, Millipore) was also used to stain mouse tissues, and an anti-cyto-
keratin 8/18 antibody (Clone Zym5.2, Invitrogen) was used for human
tissues.
Preparation of Spiked-in Control Cells
Bacterial colonies containing the plasmids with barcodes for the six individual
spiked-in controls (Table S2) were subcloned, purified by MaxiPrep (QIAGEN)
of the bacterial colonies, and used tomake a high-titer lentivirus (see ‘‘Barcode
Library Construction’’). Either FACS-purified CD10+CD90+CD49f+ human
basal mammary cells or 184-hTERT immortalized human mammary epithelial
cells (Raouf et al., 2005) were transduced as described above, and after 3 days
of preculture, 10, 20, 100, 250, 500, and 1,000 spiked-in (GFP+) control cells
were sorted per well into 96-well plates. These were combined with samples
of mouse or human mammary cells from which barcode amplicon libraries
were constructed for MPS.
Construction of Barcode Amplicon Libraries fromMouse andHuman
Mammary Cells for MPS
Samples ofmouse or humanmammary cells were each combinedwith a single
well of the presorted spiked-in controls and genomic DNA then extracted
using a PrepGEM DNA extraction kit (ZyGEM). To leverage the capacity of
current MPS sequencers to generate >109 reads in a single run, we also intro-
duced a separate fault-tolerant sequence-based index to uniquely identify
experimental groups using a plate-based library construction protocol (Fig-
ure 1A) in which barcode amplicons were generated in a 35-cycle PCR reac-
tion using sequence-specific primers with adaptors compatible with Illumina
PE1 and PE2 primers (Illumina), and then, in a second eight- to ten-cycle
PCR reaction, they were pooled at equimolar ratios and loaded into a single
lane of a flow cell for paired-end sequencing on the Illumina HiSeq 2000 or
the MiSeq platform using a custom index sequencing primer for read 2 (Wie-
gand et al., 2010). To improve cluster recognition, a control phiX library was
spiked into the amplicon libraries prior to sequencing (40% by mole by HiSeq
and 7% by MiSeq).
Computational Processing of Raw Sequencing Data from Barcoded
Samples
Barcode sequences were extracted from the resulting sequence files using
custom scripts. Only barcodes with a minimum base quality of 20 that
matched the constant regions in the 27-nucleotide barcode sequence in
both the forward and reverse direction (±three mismatches) were retrieved.
Barcode sequences were identified from the raw sequence reads using
the flanking known viral vector sequences in the forward (50-ACAA
GTAAAGCGGCCAACTCGAGAAGT AA-30) and reverse (50-CGAGCTC
GAATTTGATCAGTCGACCCCGGGCTCACTGGCCGTCGTTTTACA-30) direc-
tions. From this, a list of unique barcode sequences with corresponding
read abundance was generated, and the read values corresponding to the
spiked-in controls were used for defining a threshold and estimating clone
size.
Filtering and Thresholding Approach
Using the list of unique barcode sequences, all the single, double, and triple
mismatches were combined sequentially and the sum of the read abundance
taken for those barcodes that were grouped. The three spiked-in controls were
then retrieved. We subsequently used these spiked-in control values to elimi-
nate outlier libraries of poor quality that demonstrate poor correlation with the
known input cell number.262 Cell Stem Cell 14, 253–263, February 6, 2014 ª2014 Elsevier IncSouthern Blot Analysis
Southern blot analysis was performed using standard techniques (Sambrook
et al., 1989). Briefly, DNA extracted from individual clones was digested with
EcoRI and KpnI in separate reactions and the digested DNA electrophoresed
on a 1% agarose gel, transferred to a Zetaprobe membrane (Bio-Rad), incu-
bated with a 32P-labeled probe recognizing the GFP reporter gene, and
imaged using a phosphorimager (Molecular Dynamics).
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